Has Ronald Nelson received payments from drug or device companies?

Yes. Drug and device makers reported $2,847 in general payments to Ronald Nelson across 132 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ronald Nelson did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ronald Nelson come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ronald Nelson

Interventional Cardiology · South Bend, INNPI 1629076328

Payments from drug & device makers

$2,847in general payments, 2019–2025

Across 132 payments — averaging $21.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$654
Pfizer$330
Boston Scientific$263
Johnson & Johnson$200
Medtronic$195
Covidien LP$161
plus $1K from 22 others

What the payments were for

Food & beverage$2,847100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	33	$654
Pfizer	23	$330
Boston Scientific	4	$263
Johnson & Johnson	24	$200
Medtronic(2 entities)	2	$195
Covidien LP	4	$161
Amarin Pharma, Inc.	3	$146
Amgen	8	$115
Sanofi-aventis U.S. LLC	2	$113
Abiomed	1	$110
Heartflow, Inc.	1	$86
Boehringer Ingelheim	4	$63
Merck	3	$47
Kls-martin L.p.	2	$37
Atricure, Inc.	1	$34
United Therapeutics Corporation	1	$32
AstraZeneca	2	$31
Bayer	2	$30
Actelion Pharmaceuticals US, Inc.	2	$28
Edwards Lifesciences	1	$26
Chiesi USA, Inc.	1	$25
Angiodynamics, Inc.	1	$21
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	2	$21
Cardiovascular Systems Inc.	1	$19
Lexicon Pharmaceuticals, Inc.	1	$17
Nuwellis, Inc.	1	$17
Regeneron Healthcare Solutions, Inc.	1	$14
E.r. Squibb & Sons, L.L.C.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,847 in reported general payments places this provider in the 20th percentile of 170 interventional cardiology providers in Indiana.

See all interventional cardiology providers in Indiana →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	149	$192,248
EntrestoSacubitril/Valsartan	61	$90,715
XareltoRivaroxaban	62	$74,027
VascepaIcosapent Ethyl	30	$12,015
Atorvastatin Calcium	320	$3,219
Metoprolol Succinate	125	$1,379
Dofetilide	15	$1,110
Ezetimibe	39	$1,042
Carvedilol	111	$941
Rosuvastatin Calcium	59	$793
Metoprolol Tartrate	109	$771
Flecainide Acetate	15	$768
Amlodipine Besylate	121	$654
Lisinopril	97	$539
Warfarin Sodium	43	$521

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
PfizerEliquis	$330	$192,248149 claims
NovartisEntresto	$654	$90,71561 claims
Johnson & JohnsonXarelto	$200	$74,02762 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 20th percentile of 170 interventional cardiology providers in Indiana.

Other interventional cardiology in South Bend

Mayank MittalSouth Bend$43K
Khalid NajibSouth Bend$26K
Muhammad AslamSouth Bend$19K
Waseem BarhamSouth Bend$13K
James HermillerIndianapolis$2.8M
Jithendra ChoudaryRichmond$1.6M
Jeffrey BreallIndianapolis$955K
Samer AbbasEast Chicago$625K
Jarrod FrizzellEvansville$559K
Brian BigelowIndianapolis$444K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →